ENTERA BIO IS-0000769 (5DT) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.28x
ENTERA BIO IS-0000769 (5DT) has a Cash Flow-to-Debt Ratio of -0.28x as of June 2026, meaning its operating cash flow of €-3.46 Million could theoretically repay 0% of its total liabilities (€12.21 Million) in one year. See ENTERA BIO IS-0000769 (5DT) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.28x
Operating CF / Total Liabilities
Operating Cash Flow
€-3.46 Million
EUR
Total Liabilities
€12.21 Million
EUR
Data as of
Jun 2026
Most recent filing
ENTERA BIO IS-0000769 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for ENTERA BIO IS-0000769 across 5 annual periods. For the full cash flow conversion analysis, see 5DT cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for ENTERA BIO IS-0000769 (2021–2025)
Year-by-year debt coverage analysis for ENTERA BIO IS-0000769.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.55x | €-7.37 Million | €2.89 Million | ▲ +51.0% |
| 2024 | -5.20x | €-6.82 Million | €1.31 Million | ▲ +1.8% |
| 2023 | -5.30x | €-7.31 Million | €1.38 Million | ▲ +41.8% |
| 2022 | -9.10x | €-12.50 Million | €1.37 Million | ▼ -243.7% |
| 2021 | -2.65x | €-9.06 Million | €3.42 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.